Total Funding
45
32
Total FundingPost-IPO Equity raised
Growth Score
-32 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
72025
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
- Steve Forte: EVP, Chief Financial Officer
Daniel Durocher: Founder
About the Company
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. The company's drugs combine a proprietary high throughput gene-editing and target discovery method with high-resolution protein crystallography, computational biology and clinical informatics, enabling patients to improve cancer
treatment both with single therapy and in combination with existing drugs and treatments.
